We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$5.27B
AUM Growth
-$97.1M
Cap. Flow
-$25.4M
Cap. Flow %
-0.48%
Top 10 Hldgs %
34.76%
Holding
214
New
21
Increased
77
Reduced
92
Closed
21

Top Buys

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$50.9M
2
TDUP icon
ThredUp
TDUP
+$42.1M
3
RSKD icon
Riskified
RSKD
+$31.6M
4
MGNI icon
Magnite
MGNI
+$20.8M
5
GRBK icon
Green Brick Partners
GRBK
+$20.3M

Sector Composition

Rank Sector Weight
1 Technology 37.43%
2 Healthcare 17.99%
3 Industrials 16.43%
4 Consumer Discretionary 10.12%
5 Communication Services 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMTK
176
DELISTED
DermTech, Inc. Common Stock
DMTK
$3.08M 0.06%
95,824
+86,641
+943% +$3.04M
CYBR
177
DELISTED
CyberArk
CYBR
$3.08M 0.06%
19,492
-205
-1% -$31.2K
TPTX
178
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2.95M 0.06%
44,467
-7,884
-15% -$562K
ME
179
DELISTED
23andMe Holding Co
ME
$2.78M 0.05%
+15,321
New +$2.72M
WDC icon
180
Western Digital
WDC
$152B
$2.31M 0.04%
54,213
-312,011
-85% -$14.8M
VERI icon
181
Veritone
VERI
$135M
$2.2M 0.04%
91,950
+19,371
+27% +$395K
CALY
182
Callaway Golf Company
CALY
$3.03B
$2.02M 0.04%
+73,107
New +$2.22M
JNCE
183
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.29M 0.02%
174,175
-183,642
-51% -$1.14M
XENE icon
184
Xenon Pharmaceuticals
XENE
$6.16B
$1.28M 0.02%
83,854
+605
+0.7% +$10.5K
AUTL
185
Autolus Therapeutics
AUTL
$593M
$1.16M 0.02%
176,683
-184,272
-51% -$1.16M
XERS icon
186
Xeris Biopharma Holdings
XERS
$1.5B
$1.14M 0.02%
465,049
+14,635
+3% +$42.5K
LFMD icon
187
LifeMD
LFMD
$170M
$1.01M 0.02%
162,775
-115,477
-42% -$985K
NGNE icon
188
Neurogene
NGNE
$668M
$906K 0.02%
6,267
-3,487
-36% -$534K
DRNA
189
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$560K 0.01%
27,775
-173,737
-86% -$4.8M
CAI
190
DELISTED
CAI International, Inc.
CAI
$540K 0.01%
9,665
-50,021
-84% -$2.79M
ENPC.WS
191
DELISTED
Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
ENPC.WS
$344K 0.01%
424,193
-8,776
-2% -$7.18K
KRRO icon
192
Korro Bio
KRRO
$202M
$304K 0.01%
861
-1,689
-66% -$665K
RCEL icon
193
Avita Medical
RCEL
$251M
$282K 0.01%
15,907
+3,092
+24% +$58.3K
BGC icon
194
BGC Group
BGC
$4.84B
-2,427,118
Closed -$13.8M
PPLI
195
People Inc
PPLI
$3.02B
-52,595
Closed -$6.65M
KPTI icon
196
Karyopharm Therapeutics
KPTI
$44.9M
-48,771
Closed -$7.55M
PCRX icon
197
Pacira BioSciences
PCRX
$969M
-22,490
Closed -$1.36M
PRPL icon
198
Purple Innovation
PRPL
$29.8M
-11,358
Closed -$7.5M
RGEN icon
199
Repligen
RGEN
$9.33B
-3,976
Closed -$794K
SPNS
200
DELISTED
Sapiens International
SPNS
-289,837
Closed -$7.61M

Similar funds

Granahan Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Granahan Investment Management held 214 positions worth $5.27B, down 1.8% from $5.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Granahan Investment Management's Q3 2021 filing shows 21 new, 77 increased, 92 reduced and 21 closed positions. Its largest new stake was Riskified: 1,127,069 shares worth $25.7M. The largest sale was Cornerstone OnDemand, Inc., an estimated $54M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2021 buy was Riskified: 1,127,069 shares worth $25.7M.
  • Granahan Investment Management added most to Array Technologies in Q3 2021, an estimated $50.9M increase.
  • Granahan Investment Management's biggest Q3 2021 reduction was 2U Inc, cutting an estimated $42.4M.
  • Granahan Investment Management fully exited Cornerstone OnDemand, Inc. in Q3 2021, selling an estimated $54M.
  • Granahan Investment Management's ten largest holdings make up 35% of its $5.27B portfolio in Q3 2021.
  • Granahan Investment Management opened 21 new positions and closed 21 in Q3 2021.
  • Granahan Investment Management's portfolio value fell 1.8% quarter-over-quarter to $5.27B.

Based on Granahan Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.